- Home
- IMNM vs IIIN Comparison
IMNM vs IIIN Comparison
Compare IMNM & IIIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- IIIN
- Stock Information
- Founded
- IMNM 2006
- IIIN 1953
- Country
- IMNM United States
- IIIN United States
- Employees
- IMNM N/A
- IIIN N/A
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- IIIN Steel/Iron Ore
- Sector
- IMNM Health Care
- IIIN Industrials
- Exchange
- IMNM Nasdaq
- IIIN Nasdaq
- Market Cap
- IMNM 585.5M
- IIIN 515.0M
- IPO Year
- IMNM 2020
- IIIN N/A
- Fundamental
- Price
- IMNM $11.08
- IIIN $28.59
- Analyst Decision
- IMNM Strong Buy
- IIIN
- Analyst Count
- IMNM 5
- IIIN 0
- Target Price
- IMNM $28.60
- IIIN N/A
- AVG Volume (30 Days)
- IMNM 1.0M
- IIIN 203.5K
- Earning Date
- IMNM 03-27-2025
- IIIN 01-16-2025
- Dividend Yield
- IMNM N/A
- IIIN 3.92%
- EPS Growth
- IMNM N/A
- IIIN N/A
- EPS
- IMNM N/A
- IIIN 0.99
- Revenue
- IMNM $10,129,000.00
- IIIN $537,193,000.00
- Revenue This Year
- IMNM N/A
- IIIN $11.60
- Revenue Next Year
- IMNM N/A
- IIIN $15.97
- P/E Ratio
- IMNM N/A
- IIIN $28.82
- Revenue Growth
- IMNM N/A
- IIIN N/A
- 52 Week Low
- IMNM $8.97
- IIIN $23.60
- 52 Week High
- IMNM $30.96
- IIIN $38.40
- Technical
- Relative Strength Index (RSI)
- IMNM 54.91
- IIIN 56.23
- Support Level
- IMNM $10.29
- IIIN $27.95
- Resistance Level
- IMNM $11.43
- IIIN $29.95
- Average True Range (ATR)
- IMNM 0.77
- IIIN 0.91
- MACD
- IMNM 0.18
- IIIN 0.26
- Stochastic Oscillator
- IMNM 85.23
- IIIN 74.34
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320.
About IIIN Insteel Industries Inc.
Insteel Industries Inc manufactures steel wire reinforcing products for concrete construction applications. It manufactures and markets PC strand and welded wire reinforcement, including ESM, concrete pipe reinforcement, and standard welded wire reinforcement. The company's products are sold to manufacturers of concrete products that are used in nonresidential construction. Its concrete reinforcing products consist of two product lines: PC strand and WWR. Insteel generates its geographical revenue from the United States.